A
$ Value
$0
Shares
7,061
Price
$0
Filed
Feb 26
Insider
Name
Osterloh Albert Frederick IV
Title
—
CIK
0002111108
Roles
Director
Transaction Details
Transaction Date
2026-02-26
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
7,061
Footnotes
Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
Filing Info
Osterloh Albert Frederick IV's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-26 | DXCM | A | $0 |
Other Insiders at DXCM (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
SAYER KEVIN R
Executive Chair
|
— | — | 2026-03-08 |
|
Coleman Jon
EVP, Chief Commercial Officer
|
— | — | 2026-03-08 |
| Heller Bridgette P | — | $69K | 2026-02-12 |
|
Sylvain Jereme M
EVP, Chief Financal Officer
|
— | — | 2026-03-08 |
|
Leach Jacob Steven
President, CEO, and Director
|
— | — | 2026-03-08 |
|
Stern Sadie
EVP, Chief HR Officer
|
— | — | 2026-03-08 |
|
Brown Michael Jon
EVP, Chief Legal Officer
|
— | $217K | 2026-04-15 |